Activated Galectin‐9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia
出版年份 2021 全文链接
标题
Activated Galectin‐9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia
作者
关键词
-
出版物
FASEB JOURNAL
Volume 35, Issue 7, Pages -
出版商
Wiley
发表日期
2021-06-17
DOI
10.1096/fj.202100013r
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1−CD8+ Tumor-Infiltrating T Cells
- (2019) Sema Kurtulus et al. IMMUNITY
- Tim‐3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B
- (2019) Junyan Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer
- (2018) Jianwei Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- When worlds collide: Th17 and Treg cells in cancer and autoimmunity
- (2018) Hannah M. Knochelmann et al. Cellular & Molecular Immunology
- Soluble Galectin 9 potently enhanced regulatory T cell formation, a pathway impaired in patients with intracranial aneurysm
- (2018) Ming-Guang Zhao et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Th17 plasticity and its relevance to inflammatory bowel disease
- (2018) Aito Ueno et al. JOURNAL OF AUTOIMMUNITY
- A cellular and molecular view of T helper 17 cell plasticity in autoimmunity
- (2018) Ralph Stadhouders et al. JOURNAL OF AUTOIMMUNITY
- Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients
- (2018) Serena De Matteis et al. Journal of Translational Medicine
- Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia
- (2018) Georg Aue et al. JOURNAL OF IMMUNOLOGY
- Induction and transcriptional regulation of the co-inhibitory gene module in T cells
- (2018) Norio Chihara et al. NATURE
- Tim-3 expression and its role in hepatocellular carcinoma
- (2018) Feifei Liu et al. Journal of Hematology & Oncology
- Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
- (2018) Danbee Ha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- Cutaneous, Purpuric Painful Nodules Upon Addition of Ibrutinib to RCVP Therapy in a CLL Patient
- (2016) Joseph Justin Mulvey et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
- (2016) Ana L. Gomes et al. CANCER CELL
- Tim-3 Expression on Tumor-Infiltrating PD-1 + CD8 + T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
- (2016) Clémence Granier et al. CANCER RESEARCH
- Increased IL-10/IL-17 ratio is aggravated along with the prognosis of patients with chronic lymphocytic leukemia
- (2016) Nannan Pang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia
- (2016) M Qorraj et al. LEUKEMIA
- Negative CD4 + TIM-3 Signaling Confers Resistance Against Cold Preservation Damage in Mouse Liver Transplantation
- (2015) Y. Liu et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia
- (2015) Mehdi Yousefi et al. Future Oncology
- Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias
- (2015) Deepesh P. Lad et al. LEUKEMIA & LYMPHOMA
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
- (2014) Chuan Wu et al. IMMUNITY
- Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner
- (2012) Souichi Oomizu et al. CLINICAL IMMUNOLOGY
- Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients
- (2012) Reem Karmali et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells
- (2009) Irina Idler et al. BRITISH JOURNAL OF HAEMATOLOGY
- TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines
- (2009) William D. Hastings et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started